Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
AstraZeneca
Healthtrust
Merck
Colorcon
US Army
QuintilesIMS
McKinsey
Express Scripts

Generated: May 24, 2018

DrugPatentWatch Database Preview

NORTHERA Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Northera, and when can generic versions of Northera launch?

Northera is a drug marketed by Lundbeck Na Ltd and is included in one NDA.

The generic ingredient in NORTHERA is droxidopa. There are five drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the droxidopa profile page.
Summary for NORTHERA
Drug patent expirations by year for NORTHERA
Pharmacology for NORTHERA
Ingredient-typeCatecholamines
Physiological EffectIncreased Blood Pressure
Medical Subject Heading (MeSH) Categories for NORTHERA
Synonyms for NORTHERA
(-)-(2S,3R)-2-amino-3-hydroxy-3-(3,4-dihydroxyphenyl)propanoic acid
(-)-(2S,3R)-2-Amino-3-hydroxy-3-(3,4-dihydroxyphenyl)propionic acid
(-)-threo-3-(3,4-Dihydroxyphenyl)-L-serine
(2RS,3RS)-2-AMINO-3-(3,4-DIHYDROXY-PHENYL)-3-HYDROXY-PROPIONIC ACID
(2RS,3RS)-2-Amino-3-(3,4-dihydroxy-phenyl)-3-hydroxy-propionic acid;DL-DOPS;DL-Droxidopa
(2RS,3RS)-2-AMINO-3-(3,4-DIhydroxyphenyl)-3-HYDROXY-propanoic acid
(2S,3R)-2-amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropanoic acid
(2S,3R)-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic Acid
(2S,3R)-3,4-dihydroxy-phenylserine
(betaR)-beta,3-dihydroxy-L-tyrosine
1-14-00-00685 (Beilstein Handbook Reference)
23651-95-8
23651-95-8,1260173-94-1(HCl)
3,4-Dihydroxyphenylserine
3916-18-5
43160-12-9
492-46-6
916A185
AB01566868_01
AC1L3P81
AC1Q5QIU
AK-86903
AKOS015889899
AM009164
ANW-57465
API0002500
AX8126964
BC214748
BDBM50103611
beta,3-Dihydroxy-DL-tyrosine threo-
BRN 2852792
CCG-222060
CHEBI:31524
CHEMBL2103827
CS-2468
CTK8B7488
D,L-(3,4-Dihydroxyphenyl)serine
D01277
D0I3RO
D4235
DB06262
DL-threo-|A-(3,4-Dihydroxyphenyl)serine
DL-threo-3-(3,4-Dihydroxyphenyl)serine
DL-threo-3,4-Dihydroxyphenylserine
DL-threo-beta-(3,4-Dihydroxyphenyl)serine
DL-threo-Dihydroxyphenylserine
DL-threo-DOPS
DL-threo-Droxidopa
DL-Tyrosine, beta,3-dihydroxy-, threo-
DL-Tyrosine, beta,3-dihydroxy-, threo- (9CI)
DOPS
Dops (TN)
droxidopa
Droxidopa (JP17/INN)
Droxidopa (L-DOPS,SM-5688)
Droxidopa (L-DOPS)
Droxidopa (L-threo-3-(3,4-Dihydroxyphenyl)serine)
Droxidopa [Latin]
Droxidopa [USAN:INN:JAN]
droxidopum
EINECS 223-480-5
FT-0651749
FT-0667809
GTPL7391
H-DL--(3,4-Dihydroxyphenyl)-DL-Ser-OH
H-DL-b-(3,4-Dihydroxyphenyl)-DL-Ser-OH
HY-13458
J7A92W69L7
KB-206605
KB-62702
KS-00000ZU4
L-dihydroxyphenylserine
L-DOPS
L-DOPS, >=98% (HPLC)
L-threo 3,4-Dihydroxyphenylserine
L-threo DOPS
L-threo-3-(3,4-Dihydroxyphenyl)serine
L-threo-3,4-dihydroxyphenylserine
L-threo-dihydroxyphenylserine
L-threo-DOPS
L-Threodops
L-Tyrosine, beta,3-dihydroxy-, (beta-R)- (9CI)
L-Tyrosine, beta,3-dihydroxy-, threo-
LS-145005
MFCD00004266
MolPort-006-115-789
Norethra
Northera (TN)
Q-201050
QXWYKJLNLSIPIN-JGVFFNPUSA-N
s3041
SBB063961
SCHEMBL134299
Serine, 3-(3,4-dihydroxyphenyl)-, DL-threo-
Serine, 3-(3,4-dihydroxyphenyl)-, L-threo-
SM 5688
SM-5688
SR-01000883755
SR-01000883755-1
TC-146210
threo-2-Amino-3-(3,4-dihydroxyphenyl)-3-hydroxypropionic acid
threo-b,3-dihydroxy-l-tyrosine
threo-beta,3-Dihydroxy-DL-tyrosine
threo-Dopaserine
UNII-24A0V01WKS component QXWYKJLNLSIPIN-JGVFFNPUSA-N
UNII-J7A92W69L7
ZINC1482049

US Patents and Regulatory Information for NORTHERA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-001 Feb 18, 2014 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-002 Feb 18, 2014 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-001 Feb 18, 2014 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Lundbeck Na Ltd NORTHERA droxidopa CAPSULE;ORAL 203202-002 Feb 18, 2014 RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Boehringer Ingelheim
Express Scripts
US Army
Moodys
Merck
Colorcon
Queensland Health
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.